Table 1.
Characteristics of SPARC intervention and control hospitals
| SPARC hospitals (n=12) |
Control hospitals (n=36) |
P value* | |||
| n | % | n | % | ||
| Hospital type | |||||
| General, acute care | 12 | 100 | 35 | 97 | 1.000 |
| Medical school affiliated | |||||
| No | 3 | 25 | 17 | 47 | 0.196 |
| Yes | 9 | 75 | 19 | 53 | |
| SPARC start time | |||||
| 2018 Quarter 2 | 1 | 8 | |||
| 2018 Quarter 4 | 7 | 59 | |||
| 2019 Quarter 1 | 3 | 25 | |||
| 2019 Quarter 3 | 1 | 8 | |||
| Median | IQR | Median | IQR | P value* | |
| Number of beds | 274 | (232–339) | 146 | (88–259) | 0.015 |
| Number of intensive care unit beds | 25 | (21–64) | 14 | (8–42) | 0.054 |
| Number of infection control practitioners per 100 beds | 1.1 | (0.7–1.2) | 1.0 | (0.8–1.6) | 0.505 |
| Hours for HAI surveillance per 100 beds per week | 12 | (8–16) | 20 | (16–32) | 0.005 |
| Hours for other infection control activities per 100 beds per week | 14 | (4–34) | 24 | (13–34) | 0.239 |
| Hours for IC activities per 100 beds (sum of the hours for both surveillance and other IC activities) |
26 | (15–45) | 42 | (30–63) | 0.030 |
*From Fisher’s exact tests or Wilcoxon rank-sum tests.
HAI, hospital-acquired infection; IC, infection control; SPARC, Statewide Prevention and Reduction of C. difficile.;